Manage stand orders
Select Option
Advertisement
BioMind (Hanalytics Pte Ltd)
151, Lorong Chuan #03-01C, Lobby A, New Tech Park,
556741
Singapore
Singapore
Singapore
This company is co-exhibitor of
Singapore Manufacturing Federation
Location
Hall map
Fairground map
Contact
Our range of products
Our products
Product category: Neurological diagnosis, apparatus and instruments
BioMind
BioMind is jointly developed by world-renowned medical specialists and machine learning experts. It uses deep learning technology to analyse neurological disorders such as brain tumours, vascular diseases and stroke conditions. This AI application can also be upgraded to analyse medical images of other body systems.
About us
Company details
Hanalytics Pte Ltd (BioMind) is an Artificial Intelligence company specialising in healthcare. The company builds advanced AI technology and creates predictive applications to assist doctors diagnose medical conditions and recommend treatments. The company has a strong team of over 60 in-house deep learning scientists, medical experts, and research advisors from prestigious hospitals and universities.
In December 2018, BioMind established the world’s first and largest AI research centre for neurological diseases. The research centre, CNCRC-Hanalytics Artificial Intelligence Research Centre for Neurological Disorders (CHAIN), researches and develops AI applications covering a wide spectrum of areas including brain tumors, vascular diseases, genetics, patient rehabilitation, pathology amongst many other conditions.
BioMind is also the only company in the world to be selected as the lead for setting AI standard for radiotherapy through the AI standard committee established by ITU-WHO.
In December 2018, BioMind established the world’s first and largest AI research centre for neurological diseases. The research centre, CNCRC-Hanalytics Artificial Intelligence Research Centre for Neurological Disorders (CHAIN), researches and develops AI applications covering a wide spectrum of areas including brain tumors, vascular diseases, genetics, patient rehabilitation, pathology amongst many other conditions.
BioMind is also the only company in the world to be selected as the lead for setting AI standard for radiotherapy through the AI standard committee established by ITU-WHO.